The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma.
 
Sophia Z. Shalhout
Patents, Royalties, Other Intellectual Property - Provisional Patent on small molecules targeting the Hippo Pathway
 
Kevin S. Emerick
Honoraria - Castle Biosciences
Consulting or Advisory Role - Regeneron
 
Howard E. Kaufman
Employment - Ankyra Therapeutics
Leadership - Ankyra Therapeutics
Stock and Other Ownership Interests - Immuneering
Honoraria - Society for Immunotherapy of Cancer
Consulting or Advisory Role - Castle Biosciences
 
David M. Miller
Stock and Other Ownership Interests - Checkpoint Therapeutics
Consulting or Advisory Role - Castle Biosciences; Checkpoint Therapeutics; Merck Sharp & Dohme; Pfizer/EMD Serono; Regeneron; Sanofi/Regeneron
Research Funding - Incyte
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pfizer; Regeneron; Sanofi/Aventis